Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Res ; 32(3): 202-9, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22464807

ABSTRACT

Dietary products are among the therapeutic approaches used to modify intestinal microflora and to promote protective effects during the intestinal inflammatory process. Because the banana plant is rich in resistant starch, which is used by colonic microbiota for the anaerobic production of the short-chain fatty acids that serve as a major fuel source for colonocytes: first, green dwarf banana flour produces protective effects on the intestinal inflammation acting as a prebiotic and, second, combination of this dietary supplementation with prednisolone presents synergistic effects. For this, we used the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. Our results revealed that the protective effect produced by a combination of 10% green dwarf banana flour with prednisolone was more pronounced than those promoted by a single administration of prednisolone or a diet containing 10% or 20% banana flour. This beneficial effect was associated with an improvement in the colonic oxidative status because the banana flour diet prevented the glutathione depletion and inhibited myeloperoxidase activity and lipid peroxidation. In addition, the intestinal anti-inflammatory activity was associated with an inhibition of alkaline phosphatase activity, a reduction in macroscopic and microscopic scores, and an extension of the lesions. In conclusion, the dietary use of the green dwarf banana flour constitutes an important dietary supplement and complementary medicine product to prevention and treatment of human inflammatory bowel disease.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Colitis/therapy , Colon/drug effects , Musa/chemistry , Phytotherapy , Prednisolone/therapeutic use , Starch/therapeutic use , Alkaline Phosphatase/metabolism , Animals , Anti-Inflammatory Agents/pharmacology , Colitis/metabolism , Colitis/pathology , Colon/metabolism , Colon/pathology , Dietary Supplements , Disease Models, Animal , Drug Synergism , Flour , Fruit , Glutathione/metabolism , Inflammation/metabolism , Inflammation/pathology , Inflammation/prevention & control , Lipid Peroxidation/drug effects , Male , Oxidation-Reduction , Peroxidase/antagonists & inhibitors , Plant Preparations/pharmacology , Plant Preparations/therapeutic use , Prebiotics , Prednisolone/pharmacology , Rats, Wistar , Starch/pharmacology , Trinitrobenzenesulfonic Acid
2.
J Med Food ; 13(6): 1391-6, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21091252

ABSTRACT

Inflammatory bowel disease (IBD) is a multifactorial intestinal disorder that involves interactions among the immune system, genetic susceptibility, and environmental factors, especially the bacterial flora. Polydextrose, a polysaccharide constituted by 90% nondigestible and nonabsorbable soluble fibers, has several physiological effects consistent with those of dietary fibers, including proliferation of colon microflora. Because sulfasalazine presents serious side effects through long-term use at high doses, the aim of the present study was to evaluate the preventative effect of polydextrose on trinitrobenzenesulfonic acid-induced intestinal inflammation and its effects on the intestinal anti-inflammatory activity of sulfasalazine. Results indicated that polydextrose and its association with sulfasalazine present an anti-inflammatory effect that reduces myeloperoxidase activity, counteracts glutathione content, and promotes reductions in lesion extension and colonic weight/length ratio.


Subject(s)
Gastrointestinal Agents/therapeutic use , Glucans/therapeutic use , Inflammatory Bowel Diseases/prevention & control , Prebiotics , Alkaline Phosphatase/metabolism , Animals , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Colitis/metabolism , Colitis/pathology , Colitis/prevention & control , Colon/drug effects , Colon/metabolism , Colon/pathology , Drug Interactions , Glutathione/metabolism , Inflammatory Bowel Diseases/metabolism , Inflammatory Bowel Diseases/pathology , Male , Organ Size/drug effects , Oxidative Stress/drug effects , Peroxidase/metabolism , Random Allocation , Rats , Rats, Wistar , Severity of Illness Index , Sulfasalazine/adverse effects , Sulfasalazine/therapeutic use , Trinitrobenzenesulfonic Acid/toxicity
SELECTION OF CITATIONS
SEARCH DETAIL
...